1303-21: Pharmacologic Treatment of Bipolar Depression: Moving Beyond the Standard Paradigm

4.86 (7 votes)

  • Register
    • Non-member - $25
    • Regular Member - $15
    • Retired Member - $15
    • Affiliate Member - $15
    • Student Member - $15

1303-21:  Pharmacologic Treatment of Bipolar Depression: Moving Beyond the Standard Paradigm 

This presentation will provide an overview of evidence-based pharmacologic treatment options for bipolar depression. The use of non-traditional agents will be discussed, and participants will be able to enhance their knowledge of treatment options that can be used when standard treatments are ineffective or cause intolerable side effects.


Presenters:
  Lyons Hardy, PMHNP; Brian McCarthy, MSN

Disclosures:  The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label use of medications will be discussed during this presentation.


Session Length:
  1 hour 33 minutes

Target Audience:  APRN


Learning Outcome:
Upon completion of this presentation, the participant will be able to:

  • Discuss evidence-based pharmacologic treatment options for bipolar depression.

Keywords:  Bipolar Depression, Pharmacology, Depression


Nursing Continuing Professional Development:
1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.


Originally Presented
APNA 35th Annual Conference

The contact hours for this session expire:  November 30, 2023

Components visible upon registration.